Bilateral Vitiligo-Like Depigmentation of Choroid and Retinal Pigment Epithelium Associated with Ipilimumab-Nivolumab Therapy for Metastatic Cutaneous Melanoma

Bilateral Vitiligo-Like Depigmentation of Choroid and Retinal Pigment Epithelium Associated with Ipilimumab-Nivolumab Therapy for Metastatic Cutaneous Melanoma

Introduction: Ipilimumab and nivolumab are checkpoint inhibitors that are known to cause a multitude of inflammatory ocular adverse events. Here we report a patient with poliosis and symptomatic depigmentation of the choroid and retinal pigment epithelium (RPE) associated with checkpoint inhibitor t...

Full description

Bibliographic Details
Main Authors: Caroline C. Cotton, Anirudha S. Chandrabhatla, Mackenzie L. Higgins, Yevgeniy Shildkrot
Format: Article
Language:English
Published: Karger Publishers 2024-01-01
Series:Case Reports in Oncology
Subjects:
systemic therapy
choroidal vitiligo
checkpoint inhibitors
melanoma
oncology
Online Access:https://beta.karger.com/Article/FullText/535745

Internet

https://beta.karger.com/Article/FullText/535745

Similar Items